Did you know that some FDA Emergency Use Authorizations (EUAs) are no longer in effect? As public health conditions improve, the FDA has terminated or revoked EUAs that are no longer deemed necessary. For senior living communities, understanding these terminations is critical for ensuring compliance and maintaining effective care protocols.

Several EUAs have been revoked that directly impact senior living environments. Here are some of the most relevant examples:

1. COVID-19 Testing Devices: Many early diagnostic tests for COVID-19 received EUAs to address urgent testing needs. As newer, more accurate options became available, some older EUAs were terminated. Communities relying on specific tests should verify their current authorization status.
2. Personal Protective Equipment (PPE): Certain respirators and masks, especially those designed for emergency use, have had their EUAs revoked as supply chain issues eased and NIOSH-approved alternatives became widely accessible. This change underscores the importance of updating PPE inventories to align with approved standards.
3. Therapeutics: Early in the pandemic, monoclonal antibody treatments like bamlanivimab were issued EUAs. However, some of these authorizations have been terminated due to reduced efficacy against newer variants or the availability of superior treatments.

The FDA’s ongoing review of EUAs ensures that healthcare providers and senior living communities use the most effective and scientifically validated tools. Staying informed about these changes helps communities adjust practices, replace outdated products, and uphold the highest standards of care.

For a complete list of terminated EUAs and additional details, you can review the FDA’s archived information on Emergency Use Authorizations. Proactively adapting to these updates ensures that senior living communities continue to provide thoughtful and informed care.

Stay well and stay informed!